ADAM8 and lung carcinoma: Notably, the correlation of ADAM8 with tumour progression, metastasis, and chemoresistance in various invasive cancers, including pancreatic cancer (Yu et al., 2019), breast cancer (Conrad et al., 2018), and lung cancer (Ishikawa et al., 2004), has been previously reported.